Advertisement.

ASRT Projected Dividend Yield

Assertio Holdings Inc ( NASDAQ : ASRT )

Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products through acquisitions or licensing. Their commercial capabilities include marketing via sales force and non-personal promotion, market access through payor contracting, and trade and distribution. Key products include ROLVEDON (eflapegrastim-xnst) injection, INDOCIN (indomethacin) Suppositories and Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution), and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN products are NSAIDs.

21 YEAR PERFORMANCE RESULTS

ASRT Dividend History Detail
ASRT Dividend News
ASRT Competitors News

# of Shares: 0

Closing Price: 0.88

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000